Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Gao, Lei  [Clear All Filters]
2021
Qing Y, Dong L, Gao L, Li C, Li Y, Han L, Prince E, Tan B, Deng X, Wetzel C, et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/mA/PFKP/LDHB axis. Mol Cell. 2021.
2020
Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J, Jiang M, Bai H, Lang T, Wang J, et al. Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial. J Clin Oncol. 2020:JCO1903277.
Huang T, Yuan S, Gao L, Li M, Yu X, Zhang J, Yin Y, Liu C, Zhang C, Lu G, et al. The histone modification reader ZCWPW1 links histone methylation to PRDM9-induced double strand break repair. Elife. 2020;9.
Chai T, Shen Z, Zhang Z, Chen S, Gao L, Zhang P, Lin W, Kang M, Lin J. LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma. J Clin Lab Anal. 2020:e23121.
Huang A, Zhao X, Li M, Tang G, Fei Y, Wang R, Gao L, Ni X, Zhang W, Yang J, et al. Suppression of hematopoietic primitive cells in patients with secondary failure of platelet recovery after acute graft versus host disease. Biol Blood Marrow Transplant. 2020.
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020.
2019
Zhang C, Ma Y-Y, Liu J, Liu Y, Gao L, Gao L, Kong P-Y, Xiong Q-H, Mei W-L, Liu J, et al. Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation: Two cases report. Medicine (Baltimore). 2019;98(29):e16498.
Gao L, Xiang X, Zhang C, Gao L, Yang T, Wang S, Li B, Lou S, Lou S, Liu Y, et al. Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study. Hematology. 2019;24(1):225-231.
2015
Song N, Gao L, Qiu H, Huang C, Cheng H, Zhou H, Lv S, Chen L, Wang J. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant. Int J Mol Med. 2015.
2014
Gao L, Yu S, Zhang X. Hypothesis: Tim-3/Galectin-9, A New Pathway for Leukemia Stem Cells Survival by Promoting Expansion of Myeloid-Derived Suppressor Cells and Differentiating into Tumor-Associated Macrophages. Cell Biochem Biophys. 2014.